New Leaf Venture Partners’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-256,381
Closed -$1.01M 17
2016
Q4
$1.01M Sell
256,381
-144,000
-36% -$1.05M 0.73% 12
2016
Q3
$4.2M Sell
400,381
-54,500
-12% -$783K 3.02% 9
2016
Q2
$6.63M Sell
454,881
-41,161
-8% -$703K 5.71% 6
2016
Q1
$9.54M Sell
496,042
-50,956
-9% -$1.03M 8.64% 6
2015
Q4
$13.2M Sell
546,998
-165,500
-23% -$4.15M 8.85% 6
2015
Q3
$17.5M Buy
712,498
+100,000
+16% +$2.83M 15.17% 4
2015
Q2
$14.3M Buy
612,498
+205,505
+50% +$4.48M 9.51% 5
2015
Q1
$9.13M Buy
406,993
+294,293
+261% +$5.64M 6.2% 6
2014
Q4
$1.9M Buy
+112,700
New +$1.72M 0.92% 11

Other funds holding DVAX

New Leaf Venture Partners's DVAX Position: Q1 2017 in Review

New Leaf Venture Partners sold out of Dynavax Technologies (DVAX) in Q1 2017, closing a stake of 256,381 shares — an estimated $1.01M sold.

New Leaf Venture Partners first reported a position in DVAX in Q4 2014 and held it in 9 quarters. The position peaked at $17.5M in Q3 2015. 101 funds tracked by Wall St. Rank hold DVAX as of Q1 2017.

  • New Leaf Venture Partners reported no remaining Dynavax Technologies position as of Q1 2017 after selling out during the quarter.
  • New Leaf Venture Partners sold 256,381 Dynavax Technologies shares in Q1 2017, an estimated $1.01M.
  • New Leaf Venture Partners first reported a position in Dynavax Technologies in Q4 2014 and held it in 9 quarters.
  • New Leaf Venture Partners's Dynavax Technologies position peaked at $17.5M in Q3 2015.
  • 101 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2017.

Based on New Leaf Venture Partners's 13F filing for Q1 2017, filed 15 May 2017.